Supp. Table 4 from Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma

Authors :: Pasi A. Jänne
David M. Jackman
Geoffrey R. Oxnard
Suzanne E. Dahlberg
Christine Lydon
Mohit Butaney
Jason L. Hornick
Ashley K. Pelton
Scott J. Rodig
Lynette M. Sholl
Antonio Calles
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Table S4. LKB1 patient characteristics in KRAS mutant patients (n=148)*

Full Text Access

Tools